and has maintained a 40-year record of proven safety, efficacy and uninterrupted product supply, due in part to its unique donor program. Plasma for RhoGAM(R) Brand is sourced from a small collection site near Buffalo, N.Y. made up of approximately 300 participants. One third of the donors have been contributing to the program for more than 10 years, and some have personal reasons for doing so.
"My primary reason is simple -- I want to spare other Rh-negative expecting mothers from what I went through before RhoGAM(R) Brand was introduced," said Elizabeth Pascoe, a plasma donor for 30 years who has helped save potentially 115,000 babies' lives. "Sometimes I worry that people forget how dreadful this disease can be. I am truly grateful that my children and future generations have a way to protect against Hemolytic Disease of the Newborn."
The development of RhoGAM(R) Brand was the result of years of collaborative work by researchers at Columbia University in New York and the Ortho Research Foundation (now Ortho Clinical Diagnostics) in Raritan, N.J. When it was launched, RhoGAM(R) Brand was heralded as an obstetrical milestone. Charles Lockwood, MD, former chair of the American College of Obstetricians and Gynecologists' (ACOG) Committee on Obstetric Practice, has hailed RhoGAM(R) Brand as "one of the top achievements in 50 years of women's health."
Important Safety Information
RhoGAM(R) and MICRhoGAM(R) Ultra-Filtered PLUS Rho(D) Immune Globulin (Human) are made from human plasma. Since all plasma-derived products are made from human blood, they may carry a risk of transmitting infectious agents, e.g., viruses, and theoretically the Creutzfeldt-Jakob disease (CJD) agent. RhoGAM(R) and MICRhoGAM(R) are intended for maternal administration. Do not inject the newborn infant. Local adverse reactions may include redness, swelling, and mild pain at the site of injection and a small number
Page: 1 2 3 4 5 6 7 8 9 Related medicine news :1
|SOURCE Ortho-Clinical Diagnostics, Inc.|
Copyright©2009 PR Newswire.
All rights reserved
. Document Security Systems (Amex: DMC) Invites You to a Landmark Event2
. Less than one-third of women aware of landmark hormone therapy study, Stanford researcher finds3
. Pathway to cell death redefined in landmark study4
. Pathway to cell death redefined in landmark study5
. UCLA to lead local study center in landmark government study of child health6
. Landmark Report: Excess Body Fat Causes Cancer7
. In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack8
. Landmark trial to evaluate cardioprotective properties of insulin9
. Safeway Inc. and the Prostate Cancer Foundation to Fund Landmark Prostate Cancer Research Collaboration10
. Yale launches landmark VIRGO study of young women with heart disease11
. Hospital Launches Landmark Project in Emergency Medicine